Your browser doesn't support javascript.
loading
Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer.
Aljohani, Abrar I; Joseph, Chitra; Kurozumi, Sasagu; Mohammed, Omar J; Miligy, Islam M; Green, Andrew R; Rakha, Emad A.
Affiliation
  • Aljohani AI; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, NG7 2RD, UK.
  • Joseph C; Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.
  • Kurozumi S; School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham, UK.
  • Mohammed OJ; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, NG7 2RD, UK.
  • Miligy IM; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, NG7 2RD, UK.
  • Green AR; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, NG7 2RD, UK.
  • Rakha EA; Histopathology Department, Faculty of Medicine, Menoufia University, Shibïn al-Kawm, Egypt.
Breast Cancer Res Treat ; 181(3): 541-551, 2020 Jun.
Article in En | MEDLINE | ID: mdl-32350677

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Myxovirus Resistance Proteins Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2020 Document type: Article Affiliation country: United kingdom Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Myxovirus Resistance Proteins Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2020 Document type: Article Affiliation country: United kingdom Country of publication: Netherlands